Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
Zamanian MY, Parra RMR, Soltani A, Kujawska M, Mustafa YF, Raheem G, Al-Awsi L, Lafta HA, Taheri N, Heidari M, Golmohammadi M, Bazmandegan G. Zamanian MY, et al. Among authors: golmohammadi m. Mol Biol Rep. 2023 Jun;50(6):5455-5464. doi: 10.1007/s11033-023-08409-1. Epub 2023 May 8. Mol Biol Rep. 2023. PMID: 37155008 Review.
Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments.
Zamanian MY, Soltani A, Khodarahmi Z, Alameri AA, Alwan AMR, Ramírez-Coronel AA, Obaid RF, Abosaooda M, Heidari M, Golmohammadi M, Anoush M. Zamanian MY, et al. Among authors: golmohammadi m. Fundam Clin Pharmacol. 2023 Dec;37(6):1050-1064. doi: 10.1111/fcp.12926. Epub 2023 Jun 16. Fundam Clin Pharmacol. 2023. PMID: 37259891 Review.
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment Resistance.
Zamanian MY, Golmohammadi M, Alalak A, Kamiab Z, Obaid R, Ramírez-Coronel AA, Hjazi A, Abosaooda M, Mustafa Y, Heidari M, Verma A, Nazari Y, Bazmandegan G. Zamanian MY, et al. Among authors: golmohammadi m. Anticancer Agents Med Chem. 2023;23(16):1819-1828. doi: 10.2174/1871520623666230713101119. Anticancer Agents Med Chem. 2023. PMID: 37448364 Review.
Distinct signatures on d-galactose-induced aging and preventive/protective potency of two low-dose vitamin D supplementation regimens on working memory, muscular damage, cardiac and cerebral oxidative stress, and SIRT1 and calstabin2 downregulation.
Salemi S, Zamanian MY, Giménez-Llort L, Jalali Z, Mahmoodi M, Golmohammadi M, Kaeidi A, Taghipour Z, Khademalhosseini M, Modanloo M, Hajizadehi MR. Salemi S, et al. Among authors: golmohammadi m. Food Sci Nutr. 2023 May 22;11(9):5050-5062. doi: 10.1002/fsn3.3422. eCollection 2023 Sep. Food Sci Nutr. 2023. PMID: 37701236 Free PMC article.
Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review.
Golmohammadi M, Mahmoudian M, Hasan EK, Alshahrani SH, Romero-Parra RM, Malviya J, Hjazi A, Najm MAA, Almulla AF, Zamanian MY, Kadkhodaei M, Mousavi N. Golmohammadi M, et al. Fundam Clin Pharmacol. 2024 Apr;38(2):225-237. doi: 10.1111/fcp.12955. Epub 2023 Sep 27. Fundam Clin Pharmacol. 2024. PMID: 37753585 Review.
A narrative review of the effects of dexamethasone on traumatic brain injury in clinical and animal studies: focusing on inflammation.
Soltani A, Chugaeva UY, Ramadan MF, Saleh EAM, Al-Hasnawi SS, Romero-Parra RM, Alsaalamy A, Mustafa YF, Zamanian MY, Golmohammadi M. Soltani A, et al. Among authors: golmohammadi m. Inflammopharmacology. 2023 Dec;31(6):2955-2971. doi: 10.1007/s10787-023-01361-3. Epub 2023 Oct 16. Inflammopharmacology. 2023. PMID: 37843641 Review.
120 results